Evidence map›Paper›PMID 27427516›Full record

ArticleFree radical biology & medicine2016

Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.

Richard C Miller, Jeffrey S Murley, Alfred W Rademaker, Gayle E Woloschak, Jian Jian Li, Ralph R Weichselbaum, David J Grdina

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Richard C MillerDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Jeffrey S MurleyDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Alfred W RademakerDepartment of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States.
Gayle E WoloschakDepartment of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States.
Jian Jian LiDepartment of Radiation Oncology, The University of California Davis, Sacramento, CA, United States.
Ralph R WeichselbaumDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
David J GrdinaDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States. Electronic address: dgrdina@uchicago.edu.
University of Chicago · USNorthwestern University · USUniversity of California, Davis · US

Funding

Radiation Protectors and Radiation Therapy Coupled ChemopreventionR01CA132998 · NCI · UNIVERSITY OF CHICAGO · PI GRDINA, DAVID J. · 2009 to 2013
$1.6M
Mechanisms of Resistance to Radio Inducible Gene TherapyR01CA111423 · NCI · UNIVERSITY OF CHICAGO · PI WEICHSELBAUM, RALPH R · 2005 to 2009
$1.5M
NCI NIH HHS R01 CA111423NCI NIH HHS R01 CA132998
6 · The paper itself

Abstract

Exposure of cells to a dose of ionizing radiation as low as 5mGy can induce changes in radiation sensitivity expressed by cells exposed to subsequent higher doses at later times. This is referred to as an adaptive effect. We describe a unique survivin-associated adaptive response in which increased radiation resistance or sensitization of cells can be induced by exposure to 5mGy or to the reactive oxygen species (ROS) generating drug Emodin (1,3,8-trihydroxy-6-methylanthraquinone), a naturally occurring anthraquinone. The purpose of this study was to determine the role of ROS generating processes in affecting both the intracellular localization of the inhibitor of apoptosis protein survivin and its subsequent effect on radiation response in the presence or absence of the anti-oxidant N-acetyl-L-cysteine (NAC). Experiments were performed using two well characterized murine sarcomas: SA-NH p53 wild-type (WT) and FSa p53 mutant (Mut), grown either in culture or as solid tumors in the right hind legs of C3H mice. Doses of 5mGy or 50μM Emodin were used to induce changes in the response of these tumor cells to higher radiation exposures using a multi-dosing paradigm. Effects on radiation sensitivity were determined for SA-NH and FSa cells as a function of survivin translocation either to the cytoplasm or nucleus in the presence or absence of 10mM NAC treatment. In vitro survival assays (2Gy per fraction, two once daily fractions) and tumor growth delay (TGD) (5Gy per fraction, five once daily fractions) studies were performed. Intracellular localization of survivin was determined by enzyme-linked immunosorbent assay (ELISA) and correlated to survival response and treatment conditions. 2Gy alone had no effect on intracellular translocation of survivin. When preceded 15min earlier by 5mGy or Emodin exposures, survivin became elevated in the cytoplasm of p53 WT SA-NH as compared to the nuclei of p53 Mut FSa cells. SA-NH cells transfected with p53 small interfering RNA (siRNA), in contrast, responded similarly to p53 Mut FSa cells by becoming more radiation sensitive if exposed to 5mGy prior to each 2Gy irradiation. In contrast to their respective responses to five once daily 5Gy fractions, SA-NH tumors were protected by 5mGy exposures administered 15min prior to each daily 5Gy dose as evidenced by a more rapid growth (1.9 day decrease in TGD, P=0.032), while FSa tumors were sensitized, growing at a much slower rate (4.5 day increase in TGD, P<0.001). Exposure of SA-NH and FSa tumor cells to 10mM NAC inhibited the ability of 5mGy and Emodin to induce intracellular translocation of survivin and the corresponding altered adaptive survival response. The survivin-associated adaptive response can be induced following a multi-dosing scheme in which very low radiation doses are followed shortly thereafter by higher doses consistent with a standard image guided radiotherapy protocol that is currently widely used in the treatment of cancer. While induced by exposure to ROS generating stresses, the ultimate expression of changes in radiation response is dependent upon the bi-functionality of the tumor associated protein survivin and its intracellular translocation.

Indexed as

Gene Expression Regulation, NeoplasticAcetylcysteineAnimalsAntioxidantsCell Line, TumorCell SurvivalDose-Response Relationship, RadiationEmodinFemaleFibrosarcomaGamma RaysHindlimbInhibitor of Apoptosis ProteinsMiceMice, Inbred C3HNeoplasm TransplantationAcetylcysteineAntioxidantsBirc5 protein, mouseEmodinInhibitor of Apoptosis ProteinsOxidantsReactive Oxygen SpeciesRepressor ProteinsRNA, Small InterferingSurvivinTumor Suppressor Protein p53Adaptive responseEmodinp53Radiation responseReactive oxygen speciesSurvivin

Identifiers

PMID27427516
PMCPMC6764831
OpenAlexW2490337295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.